Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia

Bone Marrow Transplant. 1997 Jun;19(11):1085-7. doi: 10.1038/sj.bmt.1700795.

Abstract

Graft rejection has been a problem after bone marrow transplantation for patients with severe aplastic anemia (SAA). Ten children with SAA were conditioned for bone marrow transplantation from HLA-identical siblings, using cyclophosphamide (CY, 50 mg/kg) plus antithymocyte globulin (ATG, 15 mg/kg) for 4 successive days. Marrow was infused 36 h after the last dose of CY. Cyclosporin A and methotrexate were administered as graft-versus-host disease (GVHD) prophylaxis. All patients achieved durable engraftment at follow-up of 7-41+ months (mean, 25) without significant GVHD. Since investigators have used different sources, doses, and time schedules of ATG, we compared our results with other published reports. We conclude that CY/ATG conditioning is well tolerated and effective in children with SAA.

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Aplastic / therapy*
  • Antilymphocyte Serum / administration & dosage*
  • Bone Marrow Transplantation*
  • Child
  • Child, Preschool
  • Cyclophosphamide / administration & dosage*
  • Female
  • Graft vs Host Disease / etiology
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Transplantation Conditioning*
  • Transplantation, Homologous

Substances

  • Antilymphocyte Serum
  • Cyclophosphamide